Hepatoplex Two
On sale on the US market (according to the DSLD)
Health Concerns, food supplement from the US market
Hepatoplex Two (Health Concerns), a food supplement au code-barres 810034440730, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- 810034440730
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Herbal Blend | Blend | 1,950 mg |
| Capillaris Herb Extract (Artemisia capillaris) | Plant | not stated |
| Carthamus Flower Extract | Plant | not stated |
| Dong Quai root extract (Angelica sinensis) | Plant | not stated |
| Chinese Peony Root Extract | Plant | not stated |
| Chinese Salvia root extract (Salvia miltiorrhiza) | Plant | not stated |
| Bitter Orange Peel extract (Citrus aurantium) | Plant | not stated |
| Flesh-Finger Citron Peel Extract | Plant | not stated |
| Peach Kernel Extract (Prunus persica) | Plant | not stated |
| Sichuan lovage rhizome extract | Plant | not stated |
| Licorice Root Extract | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Hepatoplex Two
Entered into DSLD on 25 April 2017. On sale on the US market (according to the DSLD).- Active ingredient added : Buddha's Hand (quantity not stated)
- Active ingredient added : Capillaris (quantity not stated)
- Active ingredient added : Carthamus (quantity not stated)
- Active ingredient added : Immature Citrus (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Ligusticum (quantity not stated)
- Active ingredient added : Persica (quantity not stated)
- Active ingredient added : Proprietary Blend (750 mg)
- Active ingredient added : Red Peony (quantity not stated)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Tang Kuei (quantity not stated)
- Active ingredient removed : Bitter Orange Peel extract (quantity not stated)
- Active ingredient removed : Capillaris Herb Extract (quantity not stated)
- Active ingredient removed : Carthamus Flower Extract (quantity not stated)
- Active ingredient removed : Chinese Peony Root Extract (quantity not stated)
- Active ingredient removed : Chinese Salvia root extract (quantity not stated)
- Active ingredient removed : Dong Quai root extract (quantity not stated)
- Active ingredient removed : Flesh-Finger Citron Peel Extract (quantity not stated)
- Active ingredient removed : Licorice Root Extract (quantity not stated)
- Active ingredient removed : Peach Kernel Extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (1,950 mg)
- Active ingredient removed : Sichuan lovage rhizome extract (quantity not stated)
Official label: Hepatoplex Two
Entered into DSLD on 25 September 2013. Withdrawn from the US market on 21 March 2017 (according to the DSLD).- Active ingredient added : Buddha's Hand (quantity not stated)
- Active ingredient added : Capillaris (quantity not stated)
- Active ingredient added : Carthamus (quantity not stated)
- Active ingredient added : Immature Citrus (quantity not stated)
- Active ingredient added : Licorice (quantity not stated)
- Active ingredient added : Ligusticum (quantity not stated)
- Active ingredient added : Persica (quantity not stated)
- Active ingredient added : Proprietary Blend (Herb/Botanical) (2,250 mg)
- Active ingredient added : Red Peony (quantity not stated)
- Active ingredient added : Salvia (quantity not stated)
- Active ingredient added : Tang Kuei (quantity not stated)
- Active ingredient removed : Bitter Orange Peel extract (quantity not stated)
- Active ingredient removed : Capillaris Herb Extract (quantity not stated)
- Active ingredient removed : Carthamus Flower Extract (quantity not stated)
- Active ingredient removed : Chinese Peony Root Extract (quantity not stated)
- Active ingredient removed : Chinese Salvia root extract (quantity not stated)
- Active ingredient removed : Dong Quai root extract (quantity not stated)
- Active ingredient removed : Flesh-Finger Citron Peel Extract (quantity not stated)
- Active ingredient removed : Licorice Root Extract (quantity not stated)
- Active ingredient removed : Peach Kernel Extract (quantity not stated)
- Active ingredient removed : Proprietary Herbal Blend (1,950 mg)
- Active ingredient removed : Sichuan lovage rhizome extract (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Dong Quai root extract
Read the warning, when it applies and the studies cited
DONG QUAI - ANGELICA SINENSIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).
Sources cited by Health Canada (1)
- NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
- WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).
Sources cited by Health Canada (2)
- HC 2022: Health Canada. Traditional Chinese Medicine Ingredients monograph. [Accessed 2024 July 10]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=tcm&lang=eng
- SC 2022: Santé Canada. Monographie sur les Ingrédients de la Médecine Traditionnelle Chinoise. [Consulté le 10 juillet 2024]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=tcm&lang=fre
When using this product avoid exposure to the sun (NS 2021; Thorne 2004).
Sources cited by Health Canada (2)
- NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
- Thorne 2004: Thorne Research Inc. Monograph Angelica sinensis (Dong quai). Alternative Medicine Review 2004;9(4):429-433.
Contraindications
Do not use if you are pregnant (NS 2021; WHO 2002).
Sources cited by Health Canada (4)
- NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
- WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
- OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.
Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).
Sources cited by Health Canada (6)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
- NS 2021: Natural Standard. Dong quai (Angelica sinensis [Oliv.] Diels). [Accessed 2023 December 31]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=936
- WHO 2002: World Health Organization Monographs on Selected Medicinal Plants - Volume 2. Geneva (CH): World Health Organization; 2002.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
- OMS 2002: Organisation mondiale de la santé. Monographs on Selected Medicinal Plants - Volume 2. Genève (CH): Organisation mondiale de la santé; 2002.
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Russell L, Hicks GS, Low AK, Shepherd JM, Brown CA. Phytoestrogens: a viable option? The American Journal of the Medical Sciences 2002;324(4):185-188. PubMed Review article
- Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, Akwa Y, Rajkowski K, and Baulieu E. Novel perspectives for progesterone in Hormone Replacement Therapy, with special reference to the nervous system. Endocrine Reviews 2007;28:387-439. PubMed Review article
- Thorne 2004: Thorne Research Inc. Monograph Angelica sinensis (Dong quai). Alternative Medicine Review 2004;9(4):429-433.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Hepatoplex Two (Health Concerns): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/810034440730-hepatoplex-two-health-concerns, updated 22 January 2022.